- AU$18.00m
- AU$14.64m
- AU$0.01m
Australia Stock Exchange release from PATRYS : Response to ASX Query
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 08:53:32
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:27:30
Australia Stock Exchange release from PATRYS : Paper highlights PAT-DX1 as potential brain cancer treatment
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:45:05
Australia Stock Exchange release from PATRYS : Patrys receives R&D Tax Incentive refund
Australia Stock Exchange release from PATRYS : Shareholder Newsletter - June 2021
Australia Stock Exchange release from PATRYS : Patrys and Imagion collaborate on new cancer imaging agents
Australia Stock Exchange release from PATRYS : S708A Cleansing Notice and Appendix 2A
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:19:28
Australia Stock Exchange release from PATRYS : Appendix 4C - Quarterly - 31 March 2021
Australia Stock Exchange release from PATRYS : Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies
Australia's Patrys jumps most in nearly 2 weeks on U.S. patent grant
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:46:53
Australia Stock Exchange release from PATRYS : New United States patent granted for Patrys' deoxymab asset
Australia Stock Exchange release from PATRYS : S708A Cleansing Notice and Appendix 2A
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 18:46:39
Australia Stock Exchange release from PATRYS : Appendix 4D - Half Year Accounts - 31 December 2020
Australia Stock Exchange release from PATRYS : Appendix 2A